The deal announced by Trump and European Commission President Ursula von der Leyen at his golf club in Turnberry, Scotland, ...

A panel discussion at the e4m Health & Wellness Marketing Conference explored how pharma storytelling is shifting from ...

In a written reply to the Lok Sabha, Anupriya Patel shared that government schemes promoted domestic manufacturing of medical ...

Panaji: The India-UK free trade agreement (FTA) will significantly benefit Goa’s pharmaceutical companies, tourism sector, ...

A strategic blueprint to build India’s consulting champions — through fairer procurement rules and structural support — to ...

India has the potential to turn that principle into practice by making the next generation of therapies not only practical but also accessible and affordable. If it succeeds, India won’t just lead the ...

YANGON: The Embassy of India in Myanmar, in collaboration with the India-Myanmar Chamber of Commerce and Industry (IMCCI), hosted the "PHARMA CONNECT 2025" event on the evening of July 25 at the Pan ...

The PRIP scheme has been launched with an outlay of Rs 5,000 crore to transform India’s Pharma MedTech sector from cost- to ...

Indian pharma a formidable competitor for global manufacturing: Sameer Hiremath: Nandita Vijayasimha, Bengaluru Saturday, July 26, 2025, 08:00 Hrs [IST] Indian pharma presents an ...

The Haryana government is working on creating an industry-friendly policy framework to promote economic growth, enhance global competitiveness and ensure ease of doing business, state Cabinet Minister ...

The UK and India’s new £4.8bn free trade agreement (FTA) is expected to allow new opportunities for Indian medical device and pharmaceutical manufacturers.

Cipla , India's third-largest drugmaker by sales, reported a better-than-expected quarterly profit on Friday, driven by higher domestic demand for its generic respiratory drugs.